Safety and tolerability of single dose measured by incidence, potential significance and clinical importance of AEs, as determined by medical review of AE reports, vital sign measurements, ECGs and results of physical examination and laboratory tests Up to Day 85 after single dose of BMS-986090 [clinicaltrials_resource:d08d4f96a486c21a41d83739b1789319]
AE = Adverse event
ECG = Electrocardiogram
clinicaltrials_vocabulary:primary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:primary-outcome]
Safety and tolerability of single dose measured by incidence, potential significance and clinical importance of AEs, as determined by medical review of AE reports, vital sign measurements, ECGs and results of physical examination and laboratory tests Up to Day 85 after single dose of BMS-986090 [clinicaltrials_resource:d08d4f96a486c21a41d83739b1789319]
AE = Adverse event
ECG = Electrocardiogram
Bio2RDF identifier
d08d4f96a486c21a41d83739b1789319
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:d08d4f96a486c21a41d83739b1789319
measure [clinicaltrials_vocabulary:measure]
Safety and tolerability of sin ...... amination and laboratory tests
time frame [clinicaltrials_vocabulary:time-frame]
Up to Day 85 after single dose of BMS-986090
description
AE = Adverse event
ECG = Electrocardiogram
identifier
clinicaltrials_resource:d08d4f96a486c21a41d83739b1789319
title
Safety and tolerability of sin ...... fter single dose of BMS-986090
@en
type
label
Safety and tolerability of sin ...... d4f96a486c21a41d83739b1789319]
@en